Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor-Felix Mautner

Showing results (51-60 of 131) with videos related to

Pageof 14
Sort By:
Cancer Immunology, Immunotherapy : CII|March 21, 2020
Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic targetSaid Farschtschi, Lan Kluwe, Su-Jin Park, et al.
Orphanet Journal of Rare Diseases|January 23, 2021
Supportive care needs of patients with rare chronic diseases: multi-method, cross-sectional studyMiram K Depping, Natalie Uhlenbusch, Yskert von Kodolitsch, et al.
BMC Medical Genetics|May 1, 2015
Keratinocytic epidermal nevus syndrome with Schwann cell proliferation, lipomatous tumour and mosaic KRAS mutationSaid Farschtschi, Victor-Felix Mautner, Silke Hollants, et al.
Deutsches Arzteblatt International|July 14, 2020
The NeurofibromatosesSaid Farschtschi, Victor-Felix Mautner, Anna Cecilia Lawson McLean, et al.
Human Mutation|May 28, 2011
Monozygotic twins discordant for neurofibromatosis type 1 due to a postzygotic NF1 gene mutationJulia Vogt, Jürgen Kohlhase, Susanne Morlot, et al.
Scientific Reports|August 31, 2021
Author Correction: Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRILennart Well, Anna Careddu, Maria Stark, et al.
BMC Medical Genetics|October 30, 2012
Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletionsTanja Mußotter, Lan Kluwe, Josef Högel, et al.
Journal of Neurosurgery|February 13, 2002
Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal studyVictor-Felix Mautner, Michael E Baser, Sarang D Thakkar, et al.
Brain Research|September 4, 2015
Cerebral glucose metabolism in adults with neurofibromatosis type 1Ivayla Apostolova, Thorsten Derlin, Johannes Salamon, et al.
Human Mutation|November 5, 2013
Analysis of crossover breakpoints yields new insights into the nature of the gene conversion events associated with large NF1 deletions mediated by nonallelic homologous recombinationKathrin Bengesser, Julia Vogt, Tanja Mussotter, et al.
Pageof 14

Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
Cancer Immunology, Immunotherapy : CII|March 21, 2020
Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic targetSaid Farschtschi, Lan Kluwe, Su-Jin Park, et al.
Orphanet Journal of Rare Diseases|January 23, 2021
Supportive care needs of patients with rare chronic diseases: multi-method, cross-sectional studyMiram K Depping, Natalie Uhlenbusch, Yskert von Kodolitsch, et al.
BMC Medical Genetics|May 1, 2015
Keratinocytic epidermal nevus syndrome with Schwann cell proliferation, lipomatous tumour and mosaic KRAS mutationSaid Farschtschi, Victor-Felix Mautner, Silke Hollants, et al.
Deutsches Arzteblatt International|July 14, 2020
The NeurofibromatosesSaid Farschtschi, Victor-Felix Mautner, Anna Cecilia Lawson McLean, et al.
Human Mutation|May 28, 2011
Monozygotic twins discordant for neurofibromatosis type 1 due to a postzygotic NF1 gene mutationJulia Vogt, Jürgen Kohlhase, Susanne Morlot, et al.
Scientific Reports|August 31, 2021
Author Correction: Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRILennart Well, Anna Careddu, Maria Stark, et al.
BMC Medical Genetics|October 30, 2012
Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletionsTanja Mußotter, Lan Kluwe, Josef Högel, et al.
Journal of Neurosurgery|February 13, 2002
Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal studyVictor-Felix Mautner, Michael E Baser, Sarang D Thakkar, et al.
Brain Research|September 4, 2015
Cerebral glucose metabolism in adults with neurofibromatosis type 1Ivayla Apostolova, Thorsten Derlin, Johannes Salamon, et al.
Human Mutation|November 5, 2013
Analysis of crossover breakpoints yields new insights into the nature of the gene conversion events associated with large NF1 deletions mediated by nonallelic homologous recombinationKathrin Bengesser, Julia Vogt, Tanja Mussotter, et al.
Pageof 14